Age-Dependent Variation in Glycosylation Features of Alpha-2-Macroglobulin
Alpha-2-macroglobulin (A2M) is a glycosylated broad spectrum inhibitor of numerous proteases, including those involved in blood coagulation. Glycosylation characteristics can affect protein structure and function. This study compares glycosylation characteristics of A2M in newborn umbilical cord (NUCP) and adult pooled plasmas. Peptide N-Glycosidase F treatment was used to evaluate the total N-glycan content of the molecules. Neuraminidase treatment, and affinity for Ricinus Communis Agglutinin I were used to examine terminal sialic acid and galactose content, respectively. Two-dimensional (2D) electrophoresis was used to determine charge-related isoform profiles and fluorophore-assisted carbohydrate electrophoresis (FACE) was used to characterize N-glycan profiles. Results revealed no difference in total N-glycan mass, however, a statistically significant difference was shown in the change in charge associated with sialic acid loss in the NUCP A2M population. 2D electrophoresis indicated a lower pI range for NUCP A2M isoforms. In addition, NUCP A2M displayed a trend toward higher terminal galactose quantities than adult A2M. FACE revealed an increased abundance of more branched, higher molecular weight glycans in NUCP A2M. These differences in glycan branching and charged residues may impact A2M receptor-based clearance and thus could be responsible for the increased A2M concentration seen in NUCP, and newborns.
KeywordsAlpha-2-macroglobulin Glycosylation Plasma Newborn
We wish to thank Dr Joseph Macri for providing the 2D electrophoresis equipment and expertise. Anthony K.C. Chan holds a McMaster Children’s Hospital/Hamilton Health Sciences Foundation Chair in Pediatric Thrombosis and Hemostasis.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 4.Sottrup-Jensen, L. (1989). Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. Journal of Biological Chemistry, 264, 11539–11542.Google Scholar
- 5.Straight, D., & McKee, P. (1984). Characterization of thrombin binding to alpha 2-macroglobulin. Journal of Biological Chemistry, 259, 1272–1278.Google Scholar
- 7.Andrew, M., Paes, B., Milner, R., Johnston, M., Mitchell, L., Tollefsen, D., & Powers, P. (1987). Development of the human coagulation system in the full-term infant. Blood, 70, 165–172.Google Scholar
- 8.Andrew, M., Vegh, P., Johnston, M., Bowker, J., Ofosu, F., & Mitchell, L. (1992). Maturation of the hemostatic system during childhood. Blood, 80, 1998–2005.Google Scholar
- 9.Mitchell, L., Piovella, F., Ofosu, F., & Andrew, M. (1991). α-2-Macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children. Blood, 78(9), 2299–2304.Google Scholar
- 14.Franzen, L., Svensson, S., & Larm, O. (1980). Structural studies on the carbohydrate portion of human antithrombin III. Journal of Biological Chemistry, 255, 5090–5093.Google Scholar
- 15.Green, E., Adelt, G., Baenziger, J., Wilson, S., & Halbeek, H. (1988). The asparagine-linked oligosaccharides on bovine Fetuin. Structural analysis of N-glycanase-released oligosaccharides by 500-megahertz 1H NMR spectroscopy. Journal of Biological Chemistry, 263, 18253–18268.Google Scholar
- 20.Sottrup-Jensen, L., Stepanik, T., Kristensen, T., Wierzbicki, D., Jones, C., Lonblad, P., Magnusson, S., & Petersen, T. (1984). Primary structure of human alpha 2 macroglobulin. V. The complete structure. Journal of Biological Chemistry, 259, 8318–8327.Google Scholar